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By David B. Nash, MD, MBA
Editor-in-Chief

As I reviewed the articles for this issue
of Prescriptions for Excellence in Health
Care, I found myself wondering about
the future of the National Quality Forum
and the important priorities established
by the National Priorities Partnership
(NPP). Who will advance the agenda for
high-quality, safe, patient-centered health
care in the future?
The answer to my question became
apparent when I attended the 2nd
Annual American Medical Student
Association Quality and Safety Institute.
Over the course of this 3-day event,
more than 20 medical and premedical
students learned about cultural barriers
to quality, tools to measure quality,
and strategies to advance projects at
their home institutions. The timely
and informative sessions were taught
by faculty from the Jefferson School of
Population Health, Drexel University
College of Medicine, The National
Board of Medical Examiners, New
York Hospital Cornell Medical Center,
Robert Wood Johnson Medical School,
and Christiana Care (DE).
The bottom line is that quality and
safety can no longer be “electives” in
a medical school curriculum. While
most current faculty lack knowledge and
expertise in this field, today’s students
will ensure that this critical information

becomes part of the standard medical
school curriculum of the future.
Moreover, they will put the information
to use in their professional lives –
following the fine examples set forth by
the authors in this issue.
The lead article, “Practical Ideas for
Patient and Family Engagement in
Health Care,” offers hospitals and health
systems several practical, easily applied
suggestions for involving patients
and families in their health care. The
following article, “Care Coordination
in the Context of a Population Health
Management Model,” describes the
breadth and depth of this relatively
new field as it relates to the NPP goal
of care coordination.
The third article, “Leapfrog: Unique
and Salient Measures of Hospital Quality
and Safety,” describes a successful, highimpact health care reform initiative that
Prescriptions for Excellence in Health
Care is brought to Health Policy
Newsletter readers by Jefferson School
of Population Health in partnership
with Lilly USA, LLC to provide
essential information from the quality
improvement and patient safety arenas.

(continued on page 2)
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originated in the private purchaser sector.
The goal of “eliminating overuse while
ensuring the delivery of appropriate
care” is addressed in terms of reduction
of unwarranted procedures in the final
article, “Applying Appropriateness Methods
to Address Overuse While Ensuring
the eD livery of Appropriate Care: The
Example of Cardiac Revascularization.”

I hope that these articles will inspire
readers to become advocates for
the NPP’s National Priorities and
Goals within their organizations and,
equally important, will champion the
case for quality and safety in medical
school curricula.

As always, I am interested in your
feedback; you can reach me by e-mail
at: david.nash@jefferson.edu or visit my
blog at: nashhealthpolicy@blogspot.com.
David B. Nash, MD, MBA is
Founding Dean and the Dr. Raymond
C. and Doris N. Grandon Professor,
Jefferson School of Population Health.

A Message from Lilly
Project REPORT: Leveraging Health Information Technology to Improve Patient Safety
By Kraig Kinchen, MD
With the passage of the Health
Information Technology for
Economic and Clinical Health Act,
the United States has demonstrated
a commitment to speeding the
adoption of electronic medical
records (EMRs) by health care
providers.1 The promise of health
information technology (HIT)
often focuses on the use of EMRs
and health information exchanges
to improve the information
available to health care providers
for the delivery of care to individual
patients. Increasingly, the health
care community also is recognizing
the opportunity to improve service
delivery by leveraging HIT to gain
population-level insights about
targeted interventions.
Post-market medication safety
surveillance is an important
illustration of the potential utilization
of HIT for population-level health
care information. While extensive
clinical trials prior to a medication’s
launch provide critical information
about the benefit-risk profile of a
medication, patient safety is promoted
further through information gained
once the medication is being used in
clinical practice.
Post-market efforts to refine the
understanding of the benefit-risk
profile of a medication include

both passive and active surveillance
systems. Recently, the importance of
HIT in improving active surveillance
has received increased focus as the
Food and Drug Administration
(FDA) has moved forward with the
development of the FDA Sentinel
Network Initiative, an effort to
utilize large health care databases to
actively detect potential medicationrelated adverse events.2
Eli Lilly and Company has
worked to contribute to the
understanding of HIT-enabled active
surveillance through involvement
in multistakeholder pilot projects
including the Observational Medical
Outcomes Partnership3 and the
eHealth Initiative’s Connecting for
Drug Safety Collaboration.4
Complementing active surveillance
efforts, the passive surveillance
system relies on health care providers
and others to voluntarily submit
information on suspected medicationrelated adverse events to the FDA
through paper-based or Web-based
reports to the FDA’s MedWatch
program.5 MedWatch reports
include clinical information that
helps regulators and manufacturers
to evaluate the potential relationship
between a marketed medication
and an adverse event.6 However, a
number of factors, including perceived

time limitations of busy clinicians,
may hinder the ability of providers to
initiate efforts to populate and submit
these forms with the information that
would best facilitate evaluation.
Lilly, along with a number of other
stakeholders, recognizes that the
passive surveillance system also has
the potential to be enhanced through
HIT. The digitalization of health
care information through HIT may
offer an opportunity to improve the
quantity and quality of MedWatch
reports by auto-populating important
MedWatch fields with electronic
information from the EMR or health
information exchanges.
Project REPORT (Reporting Events
and Patient Outcomes Related to
Therapy) is a recent collaboration
between Lilly and Dr. Atif Zafar’s
team from the Regenstrief Institute
and the Indiana University (IU)
School of Medicine. For this pilot
project, Dr. Zafar’s team created a
Web-based MedWatch form that
could be populated with data from
the Indiana Health Information
Exchange (IHIE). After being
made aware of the new system,
providers at IU primary care clinics
had the ability to prepare MedWatch
forms that included imported
IHIE data on comorbid conditions,
concomitant medications, and
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relevant lab values. Subsequent to
including a brief narrative on the
potential adverse event and some
additional information, the provider
could review the form and have it
sent to the FDA through Project
REPORT. Reflecting on the Project
Report pilot project, Dr. Zafar stated,
“The REPORT system provides a
mechanism for providers to quickly
report important adverse drug events
that would otherwise go unreported
due to the time burdens associated
with the reporting process.” His
team is in the process of improving
the system as well as looking for
opportunities for partnerships that
would extend the system to other
health care providers that participate
in IHIE.
What is learned from Project
REPORT will contribute to the
growing body of information that
can be gained from other efforts to

leverage HIT to enhance the passive
surveillance system. The ASTER
(ADE Spontaneous Triggered Event
Reporting) Project, a collaboration
between Partners Healthcare, Pfizer,
and others, represents a significant
effort to enable clinicians to autopopulate MedWatch fields using
EMR data.7
Lilly hopes that such initiatives will
stimulate further multistakeholder,
collaborative efforts to improve
adverse event reporting. The timely
evaluation of data can promote a
more thorough understanding of a
medication’s benefit-risk profile and
enable clinicians to enhance patient
safety at the point of care.
Kraig Kinchen, MD, is Senior Advisor
to Electronic Exchange of Healthcare
Information at Eli Lilly and Company.
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Practical Ideas for Patient and Family Engagement in Health Care
By Maulik Joshi, DrPH
A few years ago, my then 7-year-old
daughter was hospitalized for asthma
complications. When my wife walked
into the hospital room and saw our
daughter’s medical chart on a cart by
the door, she began to look through it,
trying to understand the information.
A nurse walking by told my wife that
she could not look at the chart. She
whisked it away to the nurses’ station.
Although we noticed medical charts
outside of other patient rooms, we
never saw our daughter’s chart again.
As clinicians stood outside our
daughter’s room discussing her case
before discharge, my wife and I felt like
outsiders. We wanted to know what
we could do to control our daughter’s
asthma so she would not return to
the hospital. But our conversations

with the medical team left us without
answers to our questions. Every
conversation ended with a practitioner
telling us to call the outpatient clinic
and make an appointment with the
pediatric pulmonologist.

their health care and making decisions
about treatment and procedures.
Research has shown that engaged
patients help achieve better health
outcomes, lower service utilization,
and lower costs.2

Did we receive outstanding care at
this hospital? Yes. How was the staff?
Heroic. Could the system have better
engaged us in our daughter’s care for a
better health outcome? Absolutely!

The NPP set 3 goals to engage
patients and families:

The National Priorities Partnership
(NPP) has identified patient and
family engagement in health care as
1 of its 6 National Priorities - “…to
make health care safer, more patientcentered, affordable, and effective.”1
Patients and their families want to
become more involved in managing

•

All patients will be asked for
feedback about their experience of
care, and this information will be
used by health care organizations
and their staff to improve care.

•

All patients will have access to
tools and support systems that
enable them to effectively navigate
and manage their care.
(continued on page 4)
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All patients will have access
to information and assistance
that enables them to make
informed decisions about their
treatment options.1

The NPP also emphasizes shared
decision making as an important
underlying goal in health care —
calling for it to be “the norm for most
diagnostic and treatment processes.”1
To help achieve these goals, I offer
the following practical suggestions for
involving patients and families in their
health care. I believe that these ideas
have merit and are worth testing as a
means for achieving our overall aim.
Involve patients and families in the design
and redesign of care.
Asking patients for feedback typically
means distributing patient satisfaction
questionnaires, but it also can include
hands-on involvement for patients. For
example, hospitals and health systems
could include patients and families
on care improvement teams and
advisory councils. Such involvement
gives patients formal opportunities to
participate more directly in the design
and redesign of processes, and their
involvement and feedback helps to
accelerate the pace of improvement.
Engage patients and families in the
care process.
Two years ago, the Agency for
Healthcare Research and Quality
and the Ad Council launched a
patient involvement campaign with
a Web site called “Questions Are
the Answer” (http://www.ahrq.gov/
questionsaretheanswer/). The site
features a “question builder” that helps
patients prepare a list of questions for
medical appointments. The message to
patients is clear: get more involved in
your health care.
Hospitals and health systems can
engage patients in the care process by
including them and their families in
multidisciplinary daily patient rounds.
A study by Rosen et al compared and

evaluated conventional rounds with
family-centered multidisciplinary rounds
in an inpatient pediatric ward. After
family-centered rounds, the staff reported
better understanding of patients’ medical
plans, better ability to help the families,
and a greater sense of teamwork.3
Scheduling liberal visiting hours is another
way to engage families. A research trial
showed a positive clinical impact with a
more flexible and open visiting policy in
the intensive care unit.4 By participating
in the care process through rounds or
hospital visits and being prepared for
appointments, patients and families have
direct access to tools and support systems
that help them manage their care.
Provide patients and families with
easily accessible, meaningful, and
understandable information.
Hospitals and health systems can
begin by giving patients full and easy
access to their personal health records.
Ross and Lin reviewed outcomes
from several studies in which patients
were permitted access to their health
records. They concluded that giving
patients such access showed “modest
improvements in doctor-patient
communication, adherence, patient
empowerment, and patient education.”5
Along with access to health records,
providing customized educational
materials for each patient is important.
Customized materials are written in
the patient’s preferred language and at
an appropriate reading level. Ease of
reading is very important. NPP cites a
recent study that found that over 75%
of patients discharged from emergency
departments do not understand the
information or instructions they
receive. More alarming, a majority of
these patients do not realize that they
lack understanding.6
In addition to providing understandable
information, accommodating each
patient’s language preferences and
cultural needs ensures that the hospital
or health system is providing patientcentered care.

Address needs of patients and families
with limited English proficiency (LEP).
A national study conducted by the
Health Research & Educational Trust
found that 80% of hospitals encounter
LEP patients “frequently,” defined as
at least monthly and often weekly or
daily. Surveyed hospitals identified over
30 languages they had encountered,
from Spanish (encountered by 93%
of the hospitals) to Tagalog and Thai
(encountered by 21% and 20% of the
hospitals, respectively).7
Strategies to address the needs of
LEP patients and families include:
establishing a centralized program or
department to coordinate language
services; implementing remote or
telephonic interpretation; hiring trained
medical interpreters in high-volume
languages and bilingual staff members
with training in medical interpretation;
providing training to clinicians on how
to access and work with interpreters; and
designating more positions—particularly
clinical positions—as bilingual.
Transparency is an additional goal
when engaging patients and families.
Many hospitals and health systems
currently report clinical outcomes
including comparative costs and
quality information. As a result,
many health care consumers are
gathering information before seeking
medical treatment. Hospitals and
health systems must ensure that the
information they provide is relevant
and useful. In a recent article on
“patient-centeredness,” Berwick
suggested that hospitals “extend
transparency to all aspects of care,
including science, costs, outcomes,
processes, and errors.”8
Conclusion:
During my daughter’s hospital stay,
my wife and I wanted to become
more engaged in the care process.
Participating in rounds, having access
to her health record, or sharing in
decision making would have made us
feel less like outsiders and more like
active participants in her care. Many
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hospitals and health systems are doing
more and doing better at engaging
patients and families in the care
process. The journey continues.
Maulik Joshi, DrPH, is President of the
Health Research & Educational Trust
and Senior Vice President for Research at
the American Hospital Association. He
can be reached at: mjoshi@aha.org.
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Care Coordination in the Context of a Population Health Management Model
By Tracey Moorhead
Population health management
encompasses a broad continuum of care
services, from wellness and prevention
through disease management and
complex case management. This
continuum of care represents the
evolution of the traditional disease
management industry from one focused
on managing single chronic conditions
to one focused on managing multiple
comorbidities. It recognizes that early
intervention can keep healthy people well,
help those who are at risk stave off the
development of chronic conditions, and
educate those with chronic illnesses about
condition management techniques to
mitigate complications and exacerbations.
DMAA: The Care Continuum Alliance
provides services along all points of
this continuum - from wellness to
population health management to
disease management - via its member
organizations, which include health plans,
labor unions, employer organizations,
pharmaceutical manufacturers,
pharmacy benefit managers, health
information technology innovators
and device manufacturers, physician
groups, hospitals and hospital systems,
and academicians. These diverse

organizations share DMAA’s vision of
aligning all stakeholders to improve the
health of populations. Members seek to
maintain and improve health care quality
and restrain health care costs by providing
targeted interventions and services to
individuals who are well, at-risk, or
managing 1 or more chronic conditions.

population health improvement model
highlights 3 components:

The expansion of services to encompass
a full continuum of care, along with
the dramatic expansion of population
health management providers,
highlights the importance of careful
coordination of services and providers.
With the evolution from single-state
disease management to population
health management strategies, the focus
is on techniques and tools for improved
care coordination.

• the patient focus and capacity for
increased care coordination engendered
by wellness, disease, and chronic care
management programs.

Population Health Management Model
On behalf of the population health
management industry, DMAA: The
Care Continuum Alliance advances a
population health improvement model
that contains the elements of a fullyconnected health care system to provide
all members of the health care team
with essential tools to ensure proactive,
coordinated, quality health care. The

• the central care delivery and leadership
roles of the primary care physician;
• the critical importance of patient
activation, involvement, and personal
responsibility; and

The convergence of these roles, resources,
and capabilities in the population health
improvement model ensures higher
levels of quality and satisfaction with
care delivery. Further, coordination
and integration are important tools to
address health care workforce shortages,
individual access to coverage and care,
and affordability of care.
Accountability must be assigned for
delivering and coordinating appropriate
cost-effective care. Likewise, the
achievement of targeted improvement
and goals for population health must be
explicitly recognized and proportionately
rewarded. To this end, the population
(continued on page 6)
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health improvement model envisions
optimizing physician office practices and
other services that improve population
health and add value. To best achieve
this, payers, purchasers, patients and
their advocates, and other members
of the health care team must promote
and ensure appropriate reimbursement
schedules for cognitive services, care
coordination, referral activities, and
adherence to desired processes such as the
use of evidence-based clinical guidelines.
Key components of the population
health improvement model include:
• population identification strategies
and processes;
• comprehensive assessments of
physical, psychological, economic,
and environmental needs;
• proactive health promotion programs
that increase awareness of the health
risks associated with certain personal
behaviors and lifestyles;
• patient-centric health management
goals and education, which may
include primary prevention, behavior
modification programs, and support
for concordance between the patient
and the primary care provider;
• self-management interventions aimed
at influencing the targeted population
to make behavioral changes;
• routine reporting and feedback loops,
which may include communications
with patients, physicians, health plans,
and ancillary providers;
• evaluation of clinical, humanistic, and
economic outcomes on an ongoing
basis with the goal of improving overall
population health.
The population health improvement
model supports care coordination goals
in a wide variety of ways. First and
foremost, it encourages patients to have
a provider relationship whereby they
receive ongoing primary care in addition
to specialty care, and complements

the physician/practitioner and patient
relationship and plan of care across all
stages, including wellness, prevention,
chronic, acute, and end-of-life care.
The model supports physicians by
offering additional resources to address
gaps in patient health care literacy,
knowledge of the health care system, and
timeliness of treatment. It also provides
technical assistance to physicians – from
collecting, coordinating, and analyzing
patient-specific information and data
from patients and multiple members of
the health care team to analyzing data
across entire patient populations.
Further, the model assists unpaid
caregivers, such as family and friends,
by providing relevant information and
care coordination, and by addressing
cultural sensitivities and preferences of
individuals from disparate backgrounds.
Finally, the model promotes
care coordination by promoting
complementary care settings and
techniques, such as group visits, remote
patient monitoring, telemedicine,
telehealth, behavior modification, and
motivation techniques, for appropriate
patient populations.
Accountable measurement of progress
toward optimized population health
should include various clinical indicators
including process and outcomes
measures; assessment of patient
satisfaction with health care; functional
status and quality of life; economic
and health care utilization indicators;
and impact on known population
health disparities. These indicators
can demonstrate the effectiveness of
coordination activities across services
and providers.
Care Coordination in Population Health
Management
As already described, population
health management is a system of
coordinated health care interventions
and communications for at-risk and
chronically ill populations. Population
health management supports care

coordination by facilitating/supporting
integration across providers or care
settings to link chronically ill individuals
and their families with health education
and appropriate services and resources.
Care coordination also includes
interrelationships across health care
services and strategies, from primary
prevention and acute care to chronic
and end-of-life care. As such, care
coordination is a central component of
population health management.
The National Priorities Partnership,
convened by the National Quality
Forum (NQF), has established 6
key goals to transform health care
and create and expand world-class,
patient-centered, affordable care by
eliminating waste, harm, and disparities,
and thereby reducing disease burden.
Care coordination to ensure patientcentered, high-value care is among
these priorities and associated quality
goals include improved communication
and medication management during
transitions in care and reductions in
30-day readmissions and emergency
department visits.
The NQF defines “care coordination”
as “a function that helps ensure that
the patient’s needs and preferences for
health services and information sharing
across people, functions, and sites are
met over time. Coordination maximizes
the value of services delivered to patients
by facilitating beneficial, efficient, safe,
high-quality patient experiences and
improved health care outcomes.”
The NQF has designed 5 care
coordination domains: 1) health care
“home”; 2) proactive plan of care
and follow up; 3) communication; 4)
information systems; and 5) transitions
and “handoffs.” The population health
model encompasses these 5 domains to
achieve improved care coordination.
Summary
The population health improvement
model represents the evolution
of traditional, single disease state
management by facilitating and ensuring
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patient-focused care coordination to
improve the quality of health care
provided to individuals across the
continuum of care and services. The
population health improvement model
is closely aligned with the National
Priorities Partnership’s efforts to improve
care coordination. Aligning the goals

and components of care coordination
offered by DMAA: The Care
Continuum Alliance, the NQF, and the
National Priorities Partnership enables
the dissemination of a comprehensive
tool that all stakeholders can utilize as
they transition from single condition
programs, created and delivered in a
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silo, to whole person, whole population
health management.
Tracey Moorhead is President and Chief
Executive Officer of DMAA: The Care
Continuum Alliance. She can be reached
at: tmoorhead@dmaa.org.

Leapfrog: Unique and Salient Measures of Hospital Quality and Safety
By Leah Binder
Health care reform initiatives from
the public sector dominate the
headlines. Lesser known, but equally
dramatic, are reform initiatives
grown in the private sector. In fact,
many valuable lessons learned from
health benefits purchasers’ initiatives
have been incorporated into policy
makers’ proposals for health care
reform at the federal and state levels.
These purchaser initiatives have had
a dramatic impact on the delivery of
health care in the United States.
The Leapfrog Group (Leapfrog) is the
purchaser’s foremost agent of change
in the health care system. Founded in
the year 2000 by large employers and
business groups on health, Leapfrog
aims for “giant leaps forward in the
quality, safety, and affordability of
health care.” To accomplish this,
Leapfrog collects and publishes a
“dashboard” of information on hospital
performance and supports purchasers
in using that information to structure
their purchasing decisions. Data are
collected on performance measures
via an annual voluntary Leapfrog
Hospital Survey. Results, including
comparisons of performance among
hospitals, are reported publicly. The
current report contains data from more
than 1200 US hospitals. Leapfrog
organization members (purchasers)
agree to use the information in their
health purchasing decisions.
Research shows that if 3 of Leapfrog’s
standards (ICU staffing, electronic

medication ordering systems, and
use of higher performing hospitals
for high-risk procedures) were
implemented in all urban US hospitals,
the nation could save as many as
57,000 lives, avoid as many as 3
million adverse drug events, and save
up to $12 billion in health care costs
each year.1
Leapfrog measures are endorsed by
the National Quality Forum (NQF)
and/or are consistent with those
of The Joint Commission and the
Centers for Medicare and Medicaid
Services. Although the measures are
standardized, the information Leapfrog
collects from them is not readily
available elsewhere. Leapfrog publicly
reports and compares the variable
performance of each participating
hospital on a national scale, yielding
a unique report that reveals salient
information about hospital quality.
Selected by purchasers, Leapfrog
measures are those of greatest
importance and impact to consumers
and include: hospital mortality rates
for high-risk and common procedures,
whether hospitals undertake endorsed
methods for reducing infection, whether
hospitals deploy endorsed safe practices,
and whether hospitals have in place
management protocols and technology
that has reduced ICU deaths by 40% or
medication errors by 85%.
Because Leapfrog collects data that
is otherwise publicly unavailable and

considers measures with the greatest
impact on consumers, the results of the
survey attract considerable attention.
The results allow policy makers and
planners to pinpoint weaknesses in
safety, quality, and affordability in
US hospitals. Indeed, results from
the 2008 survey included specific
metrics to identify improvements
hospitals must undertake to achieve
performance levels that warrant the
high price Americans pay for their
health care.
Leapfrog findings from 1256 reporting
hospitals include:
• Two thirds of hospitals do not have all
of the NQF-endorsed safe practices in
place to prevent infections.
• Fewer than 1 in 4 hospitals meet
efficiency standards for heart bypass
surgery or angioplasty.
• Three quarters of hospitals fail
Leapfrog’s mortality standards for
pancreatic resection.
• Only one third of hospitals have
ICU coverage that meets Leapfrog
standards.
• Only 7% of hospitals meet Leapfrog
standards for having in place the
technology known to prevent
medication errors.
• There is a 10-fold variation between
hospitals with the lowest rates of
(continued on page 8)
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pressure ulcers and those with the
highest rates.
Overall, the survey results are
disappointing; with regard to variation
among hospitals, the results raise
serious concerns. Depending on
the measure, the highest performing
hospitals’ metrics exceed those of the
lowest performing hospitals by 4 to
10 times. Clearly, there is substantial
opportunity for improvement by the
vast majority of reporting hospitals.

value-based purchasing (ie, using good
data on hospital performance to set
reimbursement rates). Leapfrog works
with policy makers and federal agencies
to help structure new value-based
purchasing strategies for Medicare and
for health care reform proposals.

Employers throughout the country
use Leapfrog as a platform for
conversations and contracting with
hospitals. Some employers utilize
Leapfrog results as a tool in benefit
design and in pay-for-performance
programs. In addition, Leapfrog results
are commonly used by employers to
inform employees about the relative
value of hospitals in their regions.

Leapfrog’s policy on withholding
payment for “never events” (28 serious
adverse events defined by the NQF
including objects left in after surgery or
surgery on the wrong site) is consistent
with its overarching principle of tying
payment to performance. Leapfrog was
the first national organization to issue
a recommended policy on never events.
In addition to calling for hospitals to
waive all costs associated with the never
event, Leapfrog’s policy has 3 other key
features: 1) apologize to the patient, 2)
report the event to qualifying agencies,
and 3) conduct a root cause analysis to
prevent recurrence.

On a policy level, Leapfrog is one of
the nation’s pioneering champions of

The Leapfrog Survey raises serious
and disturbing questions about the

quality and cost-effectiveness of
American hospitals. With the advent
of health care reform, Leapfrog and its
purchaser members seek opportunities
to share lessons learned. Our national
experience demonstrates the value of
transparency when communicating
quality and cost-efficiency
information, as well as the advantage
of tying reimbursement policies to
performance. Collaboration among
the private and public sectors to shine
light on and reward the highest levels
of achievement among hospitals will
be essential to improve the quality
and cost-effectiveness of care in the
coming decades.
Leah Binder is Chief Executive Officer of
The Leapfrog Group. She can be reached
at: lbinder@leapfroggroup.org.
References:
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Applying Appropriateness Methods to Address Overuse While Ensuring the
Delivery of Appropriate Care: The Example of Cardiac Revascularization
By David J. Ballard, MD, MSPH, PhD
The National Priorities Partnership
(NPP) identified “eliminating
overuse while ensuring the delivery of
appropriate care” as 1 of its 6 Priorities
and Goals. Within this goal, one area
of concentration is the reduction of
unwarranted procedures, including
coronary revascularization procedures
such as coronary artery bypass grafting
(CABG) and percutaneous coronary
intervention (PCI).1 These goals are
laudable; currently, CABG is the most
common type of open-heart surgery
in the United States, with 500,000
surgeries performed per year at a
total annual cost of $50 billion. Also
common and costly, approximately 1.3
million PCI procedures are performed

in the United States each year at a total
cost of $60 billion.2
There is likely to be a larger
opportunity to reduce overuse of PCI
procedures than CABG procedures.
Application of RAND methodology
to determine appropriateness of
cardiac revascularization procedures
in 3960 Medicare beneficiaries
in 1991 and 1992 demonstrated
that 14% of PCI procedures were
inappropriate.3 The percentage of
inappropriate PCI procedures varied
from 4% to 24% across states, and half
of all PCI procedures were rated as
having uncertain appropriateness. For
CABG, variation across states was less

pronounced, with 10% of procedures
rated as inappropriate (ranging from
0% to 14%), and only 15% of CABG
surgeries rated as having uncertain
appropriateness.4
Studies of cardiac revascularization in
New York demonstrated lower rates of
inappropriate use of PCI and CABG
within that state. For patients who
underwent PCI or CABG in 1990,
the inappropriate rate of PCI use was
4% for men and 3% for women (with
34% and 40% of procedures having
uncertain appropriateness for men
and women, respectively); the rate of
inappropriate use for CABG was 2%
for men and 3% for women (with 7%
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of CABGs rated as having uncertain
appropriateness).5 Other studies of
cardiac revascularization in New York
have confirmed these rates6, 7 and drawn
attention to the larger proportion of
uncertain appropriateness associated
with PCI procedures.7

mortality and morbidity and long-term
survival appear to be related more to
risk factors and patient characteristics
than to gender.10 As mentioned, rates
of inappropriately used CABG surgery
were found to be low and similar for
men and women.5

Cross-state studies have been
more likely to examine CABG
appropriateness than PCI
appropriateness, and have found low
rates of inappropriate and uncertain
CABG use. In a study of patients who
underwent CABG surgery in 1990
in 12 US Academic Medical Center
Consortium hospitals, 2% of these
procedures were rated as inappropriate
and 7% were rated as having uncertain
appropriateness.8 More recently, a
study of 4684 CABG procedures
performed in 2004 and 2005 in
northern New England demonstrated
an appropriateness rate of 99%.9

There is scant evidence to date that the
multiyear work of the cardiovascular
physician community to produce
appropriateness ratings for cardiac
revascularization will have an impact on
achieving the NPP Priorities and Goals.17
Studies have not yet examined changes
in appropriate CABG and PCI use after
implementation of specific interventions
to improve rates of appropriate use.
The development of such interventions
should form an important focus for
future research efforts.

Despite general consensus among
experts about when CABG is
appropriate, questions have been raised
about the effectiveness of the procedure,
particularly for women.10 Early
studies suggested that women were
more likely than men to experience
in-hospital mortality and morbidity
after CABG, although long-term
survival and functional recovery were
similar in women and men.11, 12 More
recent studies have suggested that this
difference may be observed because
women have a disadvantageous
preoperative clinical profile (eg, older
age, poorer left ventricle function,
more comorbid conditions).13, 14
Smaller coronary arteries in women
may also contribute to a higher risk of
in-hospital mortality and morbidity
following CABG surgery.15
Other researchers have found that
operative mortality is higher for women
even after adjusting for comorbidities,
and have suggested that this may be
due to a referral bias that results in
later referrals for women and treatment
that occurs later in the course of the
disease.16 Overall, however, in-hospital

An additional area for future research
is the development of concurrent data
collection tools to support real-time
clinical decision making regarding the
appropriateness of PCI and CABG
surgery.18 Despite the availability of a
data collection tool,19 there has been no
effort to connect the data collected to
algorithms linked to American College
of Cardiologists’ appropriateness
ratings that enable classification of a
prospective candidate for PCI.
Examples of real-time decision-support
tools include evidence-based guidelines
that are integrated into practice
through electronic or paper-based
flow sheets and reminders, computerassisted diagnosis tools, and mandatory
solicitation of a second opinion for
high-risk procedures such as CABG
that are classified as inappropriate or as
having uncertain appropriateness.20, 21
Such tools can improve evidence-based
clinical decision making and use of
appropriate care.22, 23
Even with clinical decision-support
tools, large reductions in the overuse
of PCI are unlikely to occur without
associated financial “carrots and sticks”
that are yet to be defined. A variety of
financial incentives have been used to

9

contain costs associated with surgeries
that may be overused. As health care
costs accelerated in the 1970s, payers
began to institute the first surgical
second opinion programs (SSOPs)
and precertification requirements.21
Although overall surgery rates declined
with SSOP use, the absence of
controlled studies made it difficult to
determine whether nonconfirmation
accurately identified surgeries that
should not be performed.21
Precertification requirements, designed
to identify potentially unnecessary
operations before they are performed,
have also been used to contain
costs associated with inappropriate
surgeries. These requirements have
been used both by public programs
and commercial insurance carriers. For
example, the Peer Review Organization
(PRO) Program developed by Medicare
in the 1980s required surgeons to
obtain approval before patients could
have certain surgeries. Screening criteria
developed by individual PROs varied
widely.21 Consideration could not be
given to severity of disease, comorbidity,
possible alternative treatments, or
outcome probabilities; thus, the denial
rate for PROs nationwide was only
1.6% in 1990.24
More recently, pay-for-performance
programs, which use financial incentives
to encourage improvements in quality
and efficiency, are increasingly used to
contain health care costs and discourage
overuse. In the Centers for Medicare
and Medicaid Services Premier Hospital
Quality Incentive Demonstration
Project, small financial incentives
(limited to 1% to 2% bonuses for selected
Medicare populations) supported
improvements in quality of care for
CABG patients, including an average
improvement in the CABG quality
composite score from 84.8% to 97.4%
during the first 3 years of the project.25, 26
With respect to eliminating overuse
of cardiac revascularization, the NPP
Priorities and Goals are commendable
in light of the large number of these
(continued on page 10)
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procedures that are performed in
the United States and their high
cost. A more significant opportunity
exists to reduce inappropriate use
of PCI because it is more likely
to be performed despite uncertain
appropriateness.
In order to eliminate the overuse
of cardiac revascularization while
ensuring the delivery of appropriate
care, a variety of strategies will likely be
needed. Although the literature lacks
examples of specific interventions to
improve rates of appropriate PCI and
CABG use, real-time clinical decisionsupport tools can improve adherence
to evidence-based care and may be
useful to reduce overuse of cardiac
revascularization procedures. Even with
these tools, however, large reductions in
the overuse of PCI are unlikely to occur
without associated financial “carrots and
sticks” that are yet to be defined. Future
research should focus on identifying
and measuring the impact of specific
tactics to improve appropriate use of
cardiac revascularization procedures
David J. Ballard, MD, MSPH, PhD,
is Senior Vice President and Chief
Quality Officer for the Baylor Health
Care System, Dallas-Fort Worth, Texas.
He can be reached at:
dj.ballard@baylorhealth.edu.
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Key Healthcare Quality Organization Websites
Agency for Healthcare Research and Quality (AHRQ)
Federal agency charged with improving quality, safety, efficiency,
and effectiveness of health care.
www.ahrq.gov/qual/
AQA Alliance
Focuses on improving patient safety, healthcare quality, and value by
means of measuring performance at the physician/clinical group level and
reporting outcomes with meaningful information for decision makers.
www.aqaalliance.org/
Institute for Healthcare Improvement (IHI)
Global resources for improving the quality of health care
www.ihi.org/IHI/about
National Quality Forum
Promotes change through development and implementation of national
strategies for health care quality measurement and reporting
www.qualityforum.org/

Healthcare Quality Organization Meetings of Interest:
American Society for Quality World Conference on Quality and Improvement
St. Louis, Missouri – May 24-26, 2010
http://wcqi.asq.org/
Annual Quality Colloquium at Harvard
A hybrid conference, Internet event, and training tool
August 16-19, 2010
http://www.qualitycolloquium.com/
Joint Commission Annual Conference on Quality and Safety
Chicago, Illinois – June 23-25, 2010
http://www.jcinc.com/callforpresentations2010/annualconference/
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